3 results match your criteria: "Anhui Provincial Chest Hospital (Anhui Institute of Tuberculosis Control)[Affiliation]"
Infect Drug Resist
August 2024
Department of Tuberculosis, Anhui Provincial Chest Hospital (Anhui Institute of Tuberculosis Control), Hefei, Anhui, 230022, People's Republic of China.
Background: Linezolid (LZD) is a cornerstone medication in the treatment of drug-resistant tuberculosis (DR-TB). However, it frequently triggers adverse effects such as bone marrow suppression, optic neuropathy, and peripheral neuropathy, all of which can impact treatment outcomes and prognosis. Contezolid (CZD), a novel oxazolidinone antibiotic, exhibits comparable antimicrobial efficacy against Mycobacterium tuberculosis as LZD, but with potentially enhanced safety profiles.
View Article and Find Full Text PDFJ Multidiscip Healthc
March 2022
School of Public Health and Social Work, Queensland University of Technology, Brisbane, QLD, Australia.
BMC Psychiatry
January 2021
School of Nursing, Anhui Medical University, Hefei, 230032, Anhui, China.
Background: Coronavirus disease 2019 (COVID-19) has spread rapidly in China and other overseas areas, which has aroused widespread concern. The sharp increase in the number of patients has led to great psychological pressure on health care workers. The purpose of this study was to understand their mental health status and needs, so as to provide a scientific basis for alleviating the psychological pressure of health care workers.
View Article and Find Full Text PDF